Delivery Order 36C25221D0036-36C25222N0316
Award Date 4/1/22
Potential Completion Date 9/30/22
Potential Value $7K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cortlandt Manor, NY 10567, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Polymedco Cancer Diagnostic Products LLC, a subsidiary of Polymedco LLC, was awarded a $11,868.62 firm fixed price delivery order for IFOBT (immunochemical fecal occult blood test) products and services. The contract has no set-aside designation and will be completed by March 31, 2021. It was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to support screening programs within its healthcare system in the Cortlandt Manor, New...
- Polymedco Cancer Diagnostic Products LLC, a subsidiary of Polymedco LLC, was awarded a $8,259 firm fixed price delivery order for IFOBT (immunochemical fecal occult blood test) products and services. The award was made by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to support screening programs at its facilities located in Cortlandt Manor, New York. No set aside designation was applied to this order issued against an unspecified...
- Polymedco Cancer Diagnostic Products LLC, a subsidiary of Polymedco LLC, was awarded a $13,618 firm fixed price delivery order for IFOBT (immunochemical fecal occult blood test) products and services. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to support screening programs at medical facilities located in Cortlandt Manor, New York. No set aside designation was applied to this order issued against an...
- Polymedco Cancer Diagnostic Products LLC was awarded a $11,438 firm fixed price delivery order against an unspecified government-wide acquisition contract to provide in-office fecal occult blood tests (IFOBT) for the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. Performance will occur in Cortlandt Manor, New York, with no set-aside designation applied. As the prime contractor, Polymedco Cancer Diagnostic Products LLC is a subsidiary of...
- Polymedco LLC was awarded a $10,175.56 firm fixed price delivery order against the EO14042 IFOBT contract vehicle by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The order is for colorectal cancer screening products and services to support the VA's efforts to provide colon cancer screening to veterans. Work will be performed in Cortlandt Manor, New York, with no set-aside designation applied. The completion date is September 30,...
- Polymedco Cancer Diagnostic Products LLC was awarded a $6,895 firm fixed price delivery order for IFOBT (immunochemical fecal occult blood test) products and services. The award was made by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 without a set-aside designation. Performance will take place in Cortlandt Manor, New York. Polymedco Cancer Diagnostic Products LLC is a subsidiary of Polymedco LLC, which will perform as the prime...
- Polymedco Cancer Diagnostic Products LLC was awarded a $12,746.64 firm fixed price delivery order for IFOBT (immunochemical fecal occult blood test) products and services. The contract has no set-aside designation and is being carried out for the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12, with performance in Cortlandt Manor, New York. Polymedco Cancer Diagnostic Products LLC is a subsidiary of Polymedco LLC, which does business as...
- Polymedco Cancer Diagnostic Products LLC was awarded a $6,735.58 firm fixed price delivery order for IFOBT (immunochemical fecal occult blood test) products and services. The contract has no set-aside designation and is being carried out for the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12, with performance in Cortlandt Manor, New York. Polymedco Cancer Diagnostic Products LLC is a subsidiary of Polymedco LLC, which does business as...
- Polymedco LLC was awarded a $7,687.28 firm fixed price delivery order against an unspecified multiple award contract vehicle by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The contract calls for Polymedco to provide IFOBT (immunochemical fecal occult blood test) products with no set-aside designation utilized. Performance will take place in Madison, Wisconsin through March 31st, 2022 to support the VA's efforts in screening for...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $23,485.24 firm fixed price delivery order contract to Polymedco LLC doing business as Polymedco Cancer Diagnostic Products. The contract has a completion date of March 31, 2022 and was awarded on April 1, 2021. The contract is for IFOBT, which refers to immunochemical fecal occult blood tests, a noninvasive screening test for colon cancer. No set-aside designation was used for this...
- 36C25221D0036Indefinite Delivery Contract
- 36C25221D0036-36C25222N0316Delivery Order
Polymedco LLC, doing business as Polymedco Cancer Diagnostic Products, has been awarded a $7,011.88 firm fixed price delivery order against the EO14042 indefinite-delivery/indefinite-quantity multiple award contract vehicle by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The delivery order is for IFOBT, likely referring to immunochemical fecal occult blood tests, which screen for signs of colorectal cancer in stool samples. Performance will take place in Cortlandt Manor, New York, with all work to be completed by September 30, 2022. No set-aside provisions were applied to this award.
Generated 1/3/24, 4:37 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($8k) | 12/13/22 | |
| Not listed | Not listed | $15.3k | 3/28/22 |